Latest market price
9.45
+0.28+3.05%
TA
Loading chart...
Snapshot
| Index | — | P/E | 6.65 | EPS (ttm) | 1.42 | Insider Own | — | Shs Outstand | 116.28M | Perf Week | -1.15% |
| Market Cap | 1.10B | Forward P/E | 6.33 | EPS next Y | 1.49 | Insider Trans | 0.01% | Shs Float | 114.06M | Perf Month | 27.19% |
| Enterprise Value | 2.18B | PEG | 0.77 | EPS next Q | 0.21 | Short Float | 10.81% | Perf Quarter | -25.88% | ||
| Income | 172.00M | P/S | 0.47 | EPS this Y | 25.27% | Short Ratio | 3.28 | Perf Half Y | -45.56% | ||
| Sales | 2.35B | P/B | — | EPS next Y | 14.11% | ROA | 16.29% | Short Interest | 12.33M | Perf YTD | -64.65% |
| Book/sh | -4.02 | P/C | 21.98 | EPS next 5Y | 8.60% | ROE | — | 52W High | 33.56 -71.84% | Perf Year | -68.71% |
| Cash/sh | 0.43 | P/FCF | 4.88 | EPS past 3/5Y | 10.65% -7.86% | ROIC | 32.51% | 52W Low | 7.33 28.92% | Perf 3Y | -78.41% |
| Dividend Est. | — | EV/EBITDA | 6.58 | Sales past 3/5Y | 19.09% 18.59% | Gross Margin | 28.59% | Volatility | 4.95% 5.17% | Perf 5Y | -65.42% |
| Dividend TTM | — | EV/Sales | 0.93 | EPS Y/Y TTM | -18.86% | Oper. Margin | 13.25% | ATR (14) | 0.48 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 0.86 | Sales Y/Y TTM | 5.80% | Profit Margin | 7.28% | RSI (14) | 56.42 | Recom | 2.33 |
| Dividend Gr. 3/5Y | — | Current Ratio | 2.25 | EPS Q/Q | -45.45% | SMA20 | 5.33% | Beta | 0.43 | Target Price | 12.21 |
| Payout | 0.00% | Debt/Eq | — | Sales Q/Q | 4.01% | SMA50 | 3.55% | Rel Volume | 1.06 | Prev Close | 9.17 |
| Employees | 530 | LT Debt/Eq | — | Earnings | Nov 18 | SMA200 | -28.70% | Avg Volume | 3.61M | Price | 9.45 |
| IPO Date | Oct 18, 2019 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -18.65% 3.95% | Net Debt/EBITDA | 3.27 | Volume | 3,846,185 | Change | 3.05% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-16-26 | Reiterated | Barclays | Overweight | $14 → $12 |
| Oct-15-26 | Reiterated | UBS | Neutral | $14 → $9.50 |
| Oct-09-26 | Initiated | BNP Paribas | Outperform | $12 |
| Jul-22-26 | Reiterated | Stifel Nicolaus | $14 → $15 | |
| Jul-21-26 | Reiterated | Barclays | Overweight | $13 → $14 |
| May-15-26 | Reiterated | DA Davidson | Buy | $32 → $13 |
| May-06-26 | Reiterated | Stifel Nicolaus | $34 → $14 | |
| May-06-26 | Downgrade | Bernstein | Outperform → Market Perform | $46 → $11 |
| May-06-26 | Downgrade | Morgan Stanley | Overweight → Equal Weight | $24 → $13 |
| Apr-23-26 | Reiterated | Morgan Stanley | Overweight | $32 → $24 |
Latest News· Times ET
Oct-29-26
Oct-29-2602:52PM
06:45AM
Oct-28-26
Oct-28-2611:16PM
Oct-27-26
05:00PM
Oct-19-26
Oct-18-26
Oct-13-26
Oct-13-2602:55PM
Oct-07-26
Oct-07-2604:39PM
Oct-06-26
Oct-06-2603:43AM
Oct-05-26
Oct-04-26
Oct-04-2604:15PM
Oct-02-26
Oct-02-2612:58PM
Oct-01-26
Oct-01-2607:15PM
Company
BellRing Brands Inc., along with its various subsidiaries, is a provider of diverse nutritional products, serving both the United States and international markets. The company's main offerings are protein-fortified ready-to-drink shakes and powdered protein supplements, which are primarily marketed under its well-known Premier Protein and Dymatize labels. These items are made accessible to consumers through a wide range of distribution points, including warehouse clubs, grocery stores, pharmacies, large retail chains, online stores, specialized health shops, and convenience outlets. BellRing Brands Inc. commenced operations in 2019 and has its corporate headquarters located in Saint Louis, Missouri.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 9/30/2025 | FY 2024 9/30/2024 | FY 2023 9/30/2023 | FY 2022 9/30/2022 | FY 2021 9/30/2021 | FY 2020 9/30/2020 | FY 2019 9/30/2019 | FY 2018 9/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,354 | 2,317 | 1,996 | 1,667 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,682 | 1,546 | 1,289 | 1,137 | — | — | — | — | — | |
| Gross Profit | 673 | 770 | 707 | 530 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 345 | 396 | 285 | 204 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 12 | — | — | — | — | — | |
| Other Operating Expense | 16 | 17 | 35 | 27 | — | — | — | — | — | |
| Operating Income | 312 | 357 | 388 | 287 | — | — | — | — | — | |
| Interest Expense | 79 | 68 | 58 | 67 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 234 | 289 | 329 | 220 | — | — | — | — | — | |
| Income Taxes | 62 | 73 | 83 | 55 | — | — | — | — | — | |
| Consolidated Net Income | 172 | 216 | 247 | 166 | — | — | — | — | — | |
| Net Income From Continuing Operations | 172 | 216 | 247 | 166 | — | — | — | — | — | |
| Net Income | 172 | 216 | 247 | 166 | — | — | — | — | — | |
| EPS (Recurring) | 1.43 | 1.70 | 1.89 | 1.24 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.43 | 1.70 | 1.89 | 1.24 | — | — | — | — | — | |
| EPS (Diluted) | 1.42 | 1.68 | 1.86 | 1.23 | — | — | — | — | — | |
| EBITDA | 332 | 376 | 424 | 316 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 6.65 | 21.64 | 32.65 | 33.52 | — | — | — | — | — | |
| Price To Sales Ratio | 0.47 | 1.99 | 3.95 | 3.29 | — | — | — | — | — | |
| Gross Margin | 28.59 | 33.23 | 35.42 | 31.79 | — | — | — | — | — | |
| Operating Margin | 13.25 | 15.41 | 19.44 | 17.22 | — | — | — | — | — | |
| Net Margin | 7.31 | 9.32 | 12.37 | 9.96 | — | — | — | — | — | |
| Shares Outstanding | 116 | 127 | 130 | 133 | — | — | — | — | — | |
| Market Capitalization | 1,096 | 4,616 | 7,894 | 5,484 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CONWAY SHAWN | Director | Sep 08 '26 | Buy | 9.89 | 2,022 | 20,000 | 18,180 | Sep 09 |
| Finkelstein David Isaiah | Director | May 13 '26 | Buy | 9.23 | 4,000 | 36,940 | 13,326 | May 14 |
| Finkelstein David Isaiah | Director | Feb 13 '26 | Buy | 17.75 | 2,000 | 35,500 | 7,391 | Mar 11 |
| CORNILLE DOUGLAS J | CHIEF GROWTH OFFICER | Dec 01 '25 | Sale | 30.93 | 3,970 | 122,792 | 54,812 | Dec 03 |
| RODE PAUL A | CFO & TREASURER | Nov 07 '25 | Sale | 29.00 | 308 | 8,932 | 72,690 | Nov 12 |
| CORNILLE DOUGLAS J | CHIEF GROWTH OFFICER PNC | Sep 03 '25 | Sale | 42.03 | 3,970 | 166,859 | 53,866 | Sep 04 |
| CONWAY SHAWN | Director | Aug 14 '25 | Buy | 25018.99 | 2,632 | 65,874,087 | 8,001 | Aug 25 |
| DAVENPORT DARCY HORN | PRES. AND CEO | Aug 11 '25 | Option Exercise | 17.30 | 11,000 | 190,300 | 204,978 | Aug 12 |
| STEIN ELLIOT JR | Director | Aug 06 '25 | Buy | 37.49 | 2,663 | 99,836 | 5,198 | Aug 06 |
| CONWAY SHAWN | Director | Aug 06 '25 | Buy | 36.41 | 2,700 | 98,307 | 6,685 | Aug 06 |
| ROSENTHAL CRAIG L | CLO & SECRETARY | Aug 06 '25 | Buy | 37.29 | 2,600 | 96,958 | 33,475 | Aug 06 |
| DAVENPORT DARCY HORN | PRES. AND CEO | Aug 01 '25 | Sale | 54.18 | 1,600 | 86,688 | 193,978 | Aug 04 |
| DAVENPORT DARCY HORN | PRES. AND CEO | Jul 25 '25 | Sale | 54.43 | 1,600 | 87,088 | 195,578 | Jul 28 |
| DAVENPORT DARCY HORN | PRES. AND CEO | Jul 18 '25 | Sale | 57.70 | 1,600 | 92,325 | 197,178 | Jul 21 |
| DAVENPORT DARCY HORN | PRES. AND CEO | Jul 11 '25 | Sale | 57.66 | 1,600 | 92,256 | 198,778 | Jul 14 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.